About: Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $0.58 (-17.16%)
CTOR NASDAQ Citius Oncology, Inc.
Citius Oncology, Inc. share price
Atividade de preço de CTOR
Último preço
$ 0,570
Variação (24h)
-0,13 USD (18,54%)
Volume
69.99K
Volume (média 4 sem.)
-
Abertura
$ 0,72
Variação do dia
$ 0,51 - $ 0,72
Fechamento anterior
$ 0,70
Último negócio
23 Oct, 8:00 pm GMT+0
Atrasado
23 Oct, 8:00 pm GMT+0
CTOR price performance
Atrasado
23 Oct, 8:00 pm GMT+0
quote.marketSignals